Literature DB >> 31343317

Effect of diflunisal on clusterin levels in ATTRwt amyloidosis.

Celia Torres-Arancivia1, Lawreen H Connors1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31343317      PMCID： PMC7083542          DOI： 10.1080/13506129.2019.1582515

Source DB:  PubMed          Journal:  Amyloid        ISSN： 1350-6129            Impact factor:   7.141


× No keyword cloud information.
  3 in total

1.  Evidence for a functional role of the molecular chaperone clusterin in amyloidotic cardiomyopathy.

Authors:  Michael J Greene; Flora Sam; Pamela T Soo Hoo; Rupesh S Patel; David C Seldin; Lawreen H Connors
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

2.  Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial.

Authors:  John L Berk; Ole B Suhr; Laura Obici; Yoshiki Sekijima; Steven R Zeldenrust; Taro Yamashita; Michael A Heneghan; Peter D Gorevic; William J Litchy; Janice F Wiesman; Erik Nordh; Manuel Corato; Alessandro Lozza; Andrea Cortese; Jessica Robinson-Papp; Theodore Colton; Denis V Rybin; Alice B Bisbee; Yukio Ando; Shu-ichi Ikeda; David C Seldin; Giampaolo Merlini; Martha Skinner; Jeffery W Kelly; Peter J Dyck
Journal:  JAMA       Date:  2013-12-25       Impact factor: 56.272

3.  Plasma clusterin (ApoJ) levels are associated with adiposity and systemic inflammation.

Authors:  Jong Chul Won; Cheol-Young Park; Sang Woo Oh; Eon Sook Lee; Byung-Soo Youn; Min-Seon Kim
Journal:  PLoS One       Date:  2014-07-30       Impact factor: 3.240
  3 in total
  1 in total

Review 1.  Modulation of the Mechanisms Driving Transthyretin Amyloidosis.

Authors:  Filipa Bezerra; Maria João Saraiva; Maria Rosário Almeida
Journal:  Front Mol Neurosci       Date:  2020-12-11       Impact factor: 5.639
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.